Home › NDC Lookup › RxCUI directory › RxCUI 856660

Dantrolene sodium 50 MG Oral Capsule — RxCUI 856660

RxNorm drug concept · Semantic clinical drug
RxCUI 856660 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 19 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856660
Official nameDantrolene sodium 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped19
Reported Medicaid activity (SDUD)18,142 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dantrolene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dantrolene is used for two main things. If you're taking the capsules (Dantrium or Dantrolene Sodium), it's most likely to help control muscle stiffness and spasms caused by condit...
  • The most serious risk is liver damage. Watch for yellowing of your skin or the whites of your eyes, very dark urine, persistent nausea, or pain in the upper right side of your abdo...
  • What are the most important side effects I should watch for?
  • Dantrolene can cause liver damage — and this is the number one safety concern with long-term use. Regular blood tests (liver function tests) are the only way to catch a problem ear...
📖 Read our full Dantrolene guide →

🕸️ Concept Web — How Dantrolene sodium 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dantrolene sodium 50 MG Oral Capsule RxCUI 856660

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dantrolene 3105
    • Dantrolene sodium 3106
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dantrolene Oral Capsule 371688
    • Dantrolene sodium Oral Capsule 2647258
    • Dantrolene Oral Product 1151850
    • Dantrolene Pill 1151851
    • Dantrolene sodium Oral Product 2659141
    • Dantrolene sodium Pill 2660407
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dantrolene sodium 50 MG 856659

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dantrolene sodium 50 MG SCDC · 856659
  • Dantrolene Oral Capsule SCDF · 371688
  • Dantrolene sodium Oral Capsule SCDFP · 2647258
  • Dantrolene Oral Product SCDG · 1151850
  • Dantrolene Pill SCDG · 1151851
  • Dantrolene sodium Oral Product SCDGP · 2659141
  • Dantrolene sodium Pill SCDGP · 2660407

📦 FDA Products & Package NDCs

13 products · 19 package NDCs
19 package NDCs map to RxCUI 856660 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00115-4411-01 100 CAPSULE in 1 BOTTLE (0115-4411-01) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4411-02 500 CAPSULE in 1 BOTTLE (0115-4411-02) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4411-03 1000 CAPSULE in 1 BOTTLE (0115-4411-03) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4422-01 100 CAPSULE in 1 BOTTLE (0115-4422-01) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4422-02 500 CAPSULE in 1 BOTTLE (0115-4422-02) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4422-03 1000 CAPSULE in 1 BOTTLE (0115-4422-03) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4433-01 100 CAPSULE in 1 BOTTLE (0115-4433-01) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4433-02 500 CAPSULE in 1 BOTTLE (0115-4433-02) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
00115-4433-03 1000 CAPSULE in 1 BOTTLE (0115-4433-03) Dantrolene Sodium Amneal Pharmaceuticals of New York LLC 2005-03-01
42023-0124-01 100 CAPSULE in 1 BOTTLE (42023-124-01) Dantrium Endo USA, Inc. 2008-08-01
49884-0362-01 100 CAPSULE in 1 BOTTLE (49884-362-01) dantrolene sodium Endo USA, Inc. 2016-03-28
49884-0363-01 100 CAPSULE in 1 BOTTLE (49884-363-01) dantrolene sodium Endo USA, Inc. 2016-03-28
49884-0364-01 100 CAPSULE in 1 BOTTLE (49884-364-01) dantrolene sodium Endo USA, Inc. 2016-03-28
63629-2169-01 100 CAPSULE in 1 BOTTLE (63629-2169-1) dantrolene sodium Bryant Ranch Prepack 2021-03-11
64850-0840-01 100 CAPSULE in 1 BOTTLE (64850-840-01) Dantrolene Sodium Elite Laboratories, Inc. 2005-10-26
64850-0841-01 100 CAPSULE in 1 BOTTLE (64850-841-01) Dantrolene Sodium Elite Laboratories, Inc. 2005-10-26
64850-0842-01 100 CAPSULE in 1 BOTTLE (64850-842-01) Dantrolene Sodium Elite Laboratories, Inc. 2005-10-26
70518-4668-00 50 POUCH in 1 BOX (70518-4668-0) / 1 CAPSULE in 1 POUCH (70... dantrolene sodium REMEDYREPACK INC. 2026-05-27
72162-2046-01 100 CAPSULE in 1 BOTTLE (72162-2046-1) Dantrolene Sodium Bryant Ranch Prepack 2023-06-14
Observed labelers: Amneal Pharmaceuticals of New York LLC (9) · Endo USA, Inc. (4) · Elite Laboratories, Inc. (3) · Bryant Ranch Prepack (2) · REMEDYREPACK INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.